Literature DB >> 25968101

Hemodynamic characteristics of high-altitude headache following acute high altitude exposure at 3700 m in young Chinese men.

Shi-Zhu Bian1, Jun Jin, Qian-Ning Li, Jie Yu, Cai-Fa Tang, Rong-Sheng Rao, Shi-Yong Yu, Xiao-Hui Zhao, Jun Qin, Lan Huang.   

Abstract

BACKGROUND: This study aimed to identify the systemic and cerebral hemodynamic characteristics and their roles in high-altitude headache (HAH) among young Chinese men following acute exposure.
METHODS: The subjects (n = 385) were recruited in June and July of 2012. They completed case report form questionnaires, as well as heart rate (HR), blood pressure, echocardiogram and transcranial Doppler examinations at 3700 m following a two-hour plane flight. A subgroup of 129 participants was examined at two altitudes (500 and 3700 m).
RESULTS: HAH was characterized by increased HR and cardiac output (CO) and lower saturation pulse oxygen (SpO(2)) (all p < 0.05). The change in tricuspid regurgitation was also different between the HAH positive (HAH+) and HAH negative (HAH-) subjects. Furthermore, the HAH+ subjects exhibited faster mean (V(m)), systolic (V(s)) and diastolic (V(d)) velocities in the basilar artery (BA; all p < 0.05) and a faster V(d) ( 25.96 ± 4.97 cm/s vs. 24.76 ± 4.76 cm/s, p = 0.045) in the left vertebral artery (VA). The bilateral VA asymmetry was also significantly different between the two groups. The pulsatility index (PI) and resistance index (RI) of left VA were lower in the HAH subjects (p < 0.05) and were negatively correlated with HAH (p < 0.05). Baseline CO and Vm in left VA (or right MCA in different regressions) were independent predictors for HAH, whereas CO/HR and ΔV(d) (V(d) difference between bilateral VAs) were independent risk factors for HAH at 3700 m.
CONCLUSIONS: HAH was characterized, in part, by increased systemic hemodynamics and posterior cerebral circulation, which was reflected by the BA and left VA velocities, and lower arterial resistance and compliance. Furthermore, baseline CO and V(m) in left VA or right MCA at sea level were independent predictors for HAH, whilst bilateral VA asymmetry may contribute to the development of HAH at high altitude.

Entities:  

Mesh:

Year:  2015        PMID: 25968101      PMCID: PMC4431987          DOI: 10.1186/s10194-015-0527-3

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


Background

High-altitude headache (HAH) is the primary critical complaint after high altitude exposure [1]. It is defined as a headache that occurs within 24 hours after ascending to 2500 m or higher [2]. HAH affects tourists’ and labor workers’ daily life and work due to its high incidence and discomfort experience [3]. HAH has also been defined as the primary symptom in diagnosis of acute mountain sickness [4]. Over the past several decades, epidemiology, clinical characteristics, risk factors, prevention and treatment aspects of HAH have been systematically studied in mountaineers [5, 2, 6, 7]. Clinical characteristics studies have showed that HAH presents as a sudden attack of migraine that is accompanied by nausea [6]. Previous studies have demonstrated that increased heart rate (HR) and self-anxiety scores, lower saturation pulse oxygen (SpO2) and a history of primary headache are all independent risk factors for HAH [8, 9]. Though oxygen inhalation, acetaminophen and aspirin have been used to treat HAH, the effects are quite often inconsistent [10, 11]. Despite accumulating evidence regarding HAH and related issues, the underlying mechanisms remain elusive [12, 13, 1]. HAH exhibits an impulsivity property [14], which may be related to the hemodynamics (or blood flow in artery) of patients. While most previous studies have focused on the risk factors and epidemiology of HAH, few of them give proper attentions to the hemodynamic characteristics of HAH [8, 9, 7]. Furthermore, most of these studies have been conducted in mountaineers, which may not reflect representative properties of HAH [5, 9, 12]. To the best of our knowledge, the hemodynamic characteristics of and their roles in HAH has not been fully uncovered. Thus, we postulate that hemodynamics especially cerebral hemodynamic parameters are related HAH and they may be predictors for HAH. Therefore, we performed this large sample size cohort study to explore the hemodynamic characteristics of HAH via examinations of the systemic and cerebral hemodynamic parameters using echocardiogram and transcranial Doppler sonography, respectively, following acute high altitude exposure (within 24 h after arrival at 3700 m) to facilitate our understanding of the disease process and provide insight into the specific phenotypes associated with the disease course.

Methods

Participants and procedures

Participants

Three hundred eighty-five participants were recruited in June and July of 2012 according to specific inclusion and exclusion criteria. The inclusion criteria were as follows: healthy males between the ages of 18 and 60 years who had no high-altitude exposure in recent two years. Individuals with any of the following conditions were excluded: neuropsychosis, cerebrovascular diseases, cardiovascular diseases, respiratory diseases, malignant tumors and liver or kidney disorders. The study was reviewed and approved by the Ethics Committee of Xinqiao Hospital of Third Military Medical University. The study was thoroughly explained to all subjects who agreed to participate, and all volunteers signed informed consent forms prior to study participation.

Procedures

The subjects were transported to an altitude of 3700 m by plane over two hours of travel in June and July of 2012. None of the subjects drinks coffee regularly. The coffee, tea, and other caffeine-containing drinks as well as alcohol were avoided before the examinations. Baseline measurements of systemic and cerebral hemodynamic parameters were examined one week prior to the departure at sea level (Chengdu, 500 m) in a subgroup of 129 participants. The participants will receive regular training after a three days’ rest. They did the daily life activities and avoided any heavy exercises or physical labor in the first 72 hours at 3700 m. The field trials were performed within 18 to 24 hours after their arrivals at 3700 m. Structured case report questionnaires were used to record the subjects’ demographic information (i.e., age, body mass index (BMI), smoking and alcohol consumption), primary headache history [None of them takes medication regularly due to primary headache. However, severe headache (HAH) subjects were treated with NSAIDs or Sanlietong (Taiji medicine, Xi’an, China) as necessary at 3700 m] and HAH symptoms (0 = no headache; 1 = mild headache; 2 = moderate headache; 3 = severe headache).

Measurements of systemic hemodynamic parameters

The subjects’ systolic blood pressure (SBP), diastolic blood pressure (DBP), HR and SpO2 were measured using a sphygmomanometer (HEM-6200, OMRON, China) and a pulse oximeter (NONIN-9550, Nonin Onyx, USA) after the subjects had sat at rest for 30 min. Each subject received an echocardiogram examination (ultrasonography system, CX50, Philips, USA) that involved measurements of the end-diastolic internal diameters of the left atrium (LA), left ventricle (LV), right atrium (RA), right ventricle (RV) and pulmonary artery (PA), in addition to the stroke volume (SV), cardiac output (CO) and ejection fraction (EF).

Measurements of cerebral hemodynamic parameters

The examinations at both altitudes were performed in the morning after an overnight fast and caffeine containing drinks were avoided. Transcranial Doppler sonography examinations were performed by the same technician using an ultrasonography system with a 2 Hz probe (EME TC2021-III, NICOLET, USA). For each subject, the following parameters were recorded: the mean velocity (Vm), systolic velocity (Vs), diastolic velocity (Vd), pulsatility index (PI) and resistance index (RI). These measurements were taken in the bilateral middle cerebral artery (MCA) for anterior circulation and in the vertebral artery (VA) and basilar artery (BA) for posterior circulation. The asymmetry of the MCA and VA was calculated as ΔV = left velocity - right velocity for each lateral MCA or VA, whereas the asymmetry index (AI) was calculated as AI = ΔV/ [(left Vm + right Vm)/2]. The cerebrovascular conductance index was calculated as the Vm_MCA/mean arterial blood pressure.

Statistical analysis

The case report forms were excluded if the demographic information was not completed, the velocity could not be identified at the depths previously described or the systemic hemodynamic parameters were not measured. The normally distributed measurement variables (age, BMI, SBP, DBP, SpO2, HR, echocardiography parameters and velocities, PIs and RIs of the BA, MCAs and VAs) were expressed as the mean ± standard deviation (SD). The non-normally distributed variables were presented as the medians (interquartile range). The enumerated data are expressed as the rate of occurrence (%). The normally distributed variables for the systemic and cerebral circulation measurements were compared using a paired Student’s t-test between the 500 and 3700 m altitudes and were analyzed using an independent samples t-test between the HAH positive (HAH+) and HAH negative (HAH-) groups at both altitudes. The asymmetries, AIs and tricuspid regurgitation measurements were compared using a Mann–Whitney U test. The relationships between HAH and the previously described parameters at 500 m and 3700 m were analyzed using Spearman’s correlations. Variables with a p < 0.05 in correlation analyses or significant difference between HAH+ and HAH- groups were included in univariate logistic regression. Adjusted logistic analyses were used to identify independent predictors or risk factors for HAH after univariate logistic regression (Fig 1). Variables with colinearity were analyzed in different models (adjusted by primary variables or calculated variables respectively) to reduce the bias.
Fig. 1

The fluidogram of the statistical analysis

The fluidogram of the statistical analysis The statistical analyses were performed using SPSS 19.0 software for Windows. P ≤ 0.05 was considered statistically significant. Statisticians from Third Military Medical University were consulted regarding the statistical methods and results.

Results

Clinical characteristics of the subjects

Three hundred eighty-five subjects received both echocardiography and transcranial Doppler examinations at 3700 m of elevation (363 subjects had completely valid transcranial Doppler and echocardiography parameters). Baseline measurements at 500 m were also recorded among 129 individuals. The subjects in this study were characterized by a mean age of 23.35 ± 4.37 years and a mean BMI of 21.81 ± 2.50 kg/m2. The ethnicity of the population was primarily Han Chinese (83.2%). Overall, in our study, the incidence of HAH following acute exposure to 3700 m was 75.2% (273 of 363).

Alterations in systemic and cerebral hemodynamics

Both systemic and cerebral circulations were dramatically altered following acute exposure to high altitude from sea level. However, the blood pressure parameters, including the SBP, DBP, pulse pressure and mean arterial blood pressure, did not significantly increase after the acute exposure. The SpO2 decreased from 98.34 ± 1.06% to 88.72 ± 2.71% (p < 0.001). The LA, RA and RV all significantly decreased (all p < 0.001). However, the EF and CO significantly increased, as well as the velocity in the bilateral MCAs. In VAs and BA, the Vd exhibited a significant increase. However, the VAs asymmetries did not dramatically change. The changes in the hemodynamic parameters are summarized in Table 1.
Table 1

Alterations in systemic and cerebral hemodynamics (N = 129)

Sea level3700 mp value
Systemic hemodynamics
SBP116.32 ± 15.24115.84 ± 11.840.782
DBP74.65 ± 10.9376.24 ± 9.400.156
ΔBP41.67 ± 11.7139.61 ± 8.050.131
MAP88.54 ± 11.2589.44 ± 9.550.444
HR63.58 ± 10.1983.98 ± 11.90<0.001**
SpO2 98.34 ± 1.0688.72 ± 2.71<0.001**
LA30.91 ± 1.7330.00 ± 1.92<0.001**
LV46.47 ± 2.4546.15 ± 2.040.184
RA35.70 ± 2.2334.21 ± 2.15<0.001**
RV35.49 ± 2.0833.72 ± 2.42<0.001**
PA20.24 ± 1.6019.92 ± 1.600.097
EF62.94 ± 5.4966.56 ± 3.92<0.001**
SV65.24 ± 12.2267.30 ± 8.310.088
CO4.16 ± 0.955.32 ± 1.09<0.001**
Tricuspid regurgitation0.500 (1.00)0.500(0.500)0.885
Cerebral hemodynamics
Left side MCA
Vm 62.08 ± 10.3965.79 ± 11.78<0.001**
Vs 95.95 ± 14.6099.80 ± 15.930.002**
Vd 42.69 ± 7.9146.47 ± 9.07<0.001**
PI0.867 ± 0.1330.817 ± 0.133<0.001**
RI0.554 ± 0.0480.534 ± 0.048<0.001**
Left side VA
Vm_ 32.77 ± 5.1435.20 ± 5.83<0.001**
Vs_ 50.70 ± 7.5051.57 ± 7.910.233
Vd_ 21.91 ± 4.09524.82 ± 4.86<0.001**
PI0.895 ± 0.1810.770 ± 0.168<0.001**
RI0.570 ± 0.0670.516 ± 0.061<0.001**
Right side MCA
Vm 58.79 ± 10.1863.25 ± 11.58<0.001**
Vs 90.50 ± 14.1894.71 ± 15.01<0.001**
Vd 40.35 ± 7.4944.55 ± 9.04<0.001**
PI0.864 ± 0.1500.804 ± 0.130<0.001**
RI0.556 ± 0.0550.530 ± 0.0500.293
Right side VA
Vm 34.33 ± 4.7736.47 ± 5.73<0.001**
Vs 50.60 ± 6.5551.78 ± 7.830.058
Vd 23.24 ± 4.1225.90 ± 4.55<0.001**
PI0.808 ± 0.1620.715 ± 0.117<0.001**
RI0.539 ± 0.0610.499 ± 0.048<0.001**
BA
Vm 39.66 ± 7.7541.85 ± 9.580.002**
Vs 67.93 ± 13.5766.19 ± 13.460.117
Vd 25.07 ± 5.8528.59 ± 7.71<0.001**
PI1.093 ± 0.2510.920 ± 0.220<0.001**
RI0.627 ± 0.0680.567 ± 0.073<0.001**
Asymmetry of the bilateral VAs
ΔVs 0.0 (11.0)0.0 (12.0)0.645
ΔVd −1.0 (6.0)−1.0 (6.0)0.623
ΔVm −1.0 (7.0)−2.0 (8.0)0.529
AI%−3.5 (20.2)−2.9 (18.1)0.190
Conduction
CVCi0.695 ± 0.1450.730 ± 0.1490.011*

BA: basilar artery; CO: cardiac output; CVCi : cerebrovascular conductance index; DBP: diastolic blood pressure; EF: ejection fraction; HAH: high-altitude headache; HAH+: HAH positive or with HAH; HAH-: HAH negative or without HAH;HR: heart rate; LA: end-diastolic internal diameters of left atrium; LV: end-diastolic internal diameters of left ventricle; MCA: middle cerebral artery; PA: end-diastolic internal diameters of pulmonary artery; PI: pulsatility index; RA: end-diastolic internal diameters of right atrium; RI: resistance index; RV: end-diastolic internal diameters of right ventricle; SBP: systolic blood pressure;SpO2: saturation pulse oxygen; SV: stroke volume; VA: vertebral artery; Vs: systolic velocity; Vd: diastolic velocity; Vm: mean velocity;ΔVs: difference in systolic velocity between bilateral isonym cerebral arteries; ΔVd: difference in diastolic velocity between bilateral isonym cerebral arteries;ΔVm: Difference in mean velocity between bilateral isonym cerebral arteries. Cerebrovascular conductance index (CVCi) = Vm_MCA/MAP

#: N = 129;

*p is 0.05 or less, **p is 0.01 or less

Most of the cerebral hemodynamic parameters altered dramatically from sea level to 3700 m and systemic hemodynamic parameters altered dramatically in part

Alterations in systemic and cerebral hemodynamics (N = 129) BA: basilar artery; CO: cardiac output; CVCi : cerebrovascular conductance index; DBP: diastolic blood pressure; EF: ejection fraction; HAH: high-altitude headache; HAH+: HAH positive or with HAH; HAH-: HAH negative or without HAH;HR: heart rate; LA: end-diastolic internal diameters of left atrium; LV: end-diastolic internal diameters of left ventricle; MCA: middle cerebral artery; PA: end-diastolic internal diameters of pulmonary artery; PI: pulsatility index; RA: end-diastolic internal diameters of right atrium; RI: resistance index; RV: end-diastolic internal diameters of right ventricle; SBP: systolic blood pressure;SpO2: saturation pulse oxygen; SV: stroke volume; VA: vertebral artery; Vs: systolic velocity; Vd: diastolic velocity; Vm: mean velocity;ΔVs: difference in systolic velocity between bilateral isonym cerebral arteries; ΔVd: difference in diastolic velocity between bilateral isonym cerebral arteries;ΔVm: Difference in mean velocity between bilateral isonym cerebral arteries. Cerebrovascular conductance index (CVCi) = Vm_MCA/MAP #: N = 129; *p is 0.05 or less, **p is 0.01 or less Most of the cerebral hemodynamic parameters altered dramatically from sea level to 3700 m and systemic hemodynamic parameters altered dramatically in part

Clinical and hemodynamic characteristics of HAH at 3700 m

Only age (p = 0.044) was significantly higher in the HAH+ group as compared with the HAH- group regarding demographic data. The HAH+ patients were characterized by increased HR (87.96 ± 13.02 vs. 84.41 ± 13.11 beats per min, p = 0.026) and decreased SpO2 (87.94 ± 3.19 vs. 88.70 ± 2.98%, p = 0.048). Regarding blood pressure, there was no significant difference between the HAH+ and HAH- groups in the SBP, DBP, pulse pressure or mean arterial blood pressure. Although the LA, LV, RA, RV, PA, EF, SV and tricuspid regurgitation were not significantly different in the HAH+ subjects compared with the HAH- subjects (all p > 0.05), the CO was significantly increased in the HAH+ group (p = 0.001). Anterior circulation, which was assessed via measurements of velocities in MCAs, was similar in the HAH+ and HAH- groups in bilateral MCAs (all p > 0.05). The PIs and RIs in the right and left MCA were not different between the two groups. For posterior circulation, the velocities in BA, including Vs (65.46 ± 11.54 vs. 68.81 ± 14.84, p = 0.028), Vd (28.61 ± 7.46 vs. 30.47 ± 7.52, p = 0.042) and Vm (41.42 ± 8.64 vs. 44.18 ± 9.74, p = 0.017), were significantly different in the HAH- group as compared with the HAH+ group, respectively. Similar to the MCA, the PI (p = 0.151) and RI (p = 0.292) of the BA were not significantly different between the HAH+ and HAH- groups. Furthermore, the Vd in left VA was significantly increased in the HAH+ group compared with the HAH- group (25.96 ± 4.97 vs. 24.76 ± 4.76 cm/s, p = 0.045), whereas the Vs and Vm were not significantly different between the two groups. Additionally, the HAH+ patients also exhibited a lower RI and PI in the left VA (p = 0.040 and 0.025, respectively). However, in the right VA, the velocities and pulsate indexes showed no differences between HAH+ group and HAH- one (all p > 0.05, Table 2).
Table 2

Differences between HAH+ and HAH- groups in demographics, systemic and cerebral hemodynamics (N = 363)

Headachea HAH-HAH+HAH intensitiesp (H+ vs. H-)
Cases(n)(90)(273)Mild (215)Moderate (52)Sever (6)
Demographic factors
Age22.59 ± 3.9523.60 ± 4.4823.12 ± 4.2625.47 ± 4.9925.00 ± 3.690.044*
BMI21.52 ± 2.1121.90 ± 2.6121.85 ± 2.5521.96 ± 2.8923.56 ± 2.090.199
Smoking(yes)20(22.2%)66(24.2%)52(24.2%)11(21.2%)3(50.0%)0.705
Alcohol consumption(yes)54(60.0%)159(58.2%)126 (58.6%)28(53.8%)5(83.3%)0.796
Systemic hemodynamics
SBP117.28 ± 11.62118.66 ± 12.03118.84 ± 12.38118.17 ± 11.04116.67 ± 7.760.340
DBP77.52 ± 10.8378.86 ± 9.9778.89 ± 10.2178.92 ± 9.2677.33 ± 8.430.279
ΔBP39.76 ± 7.1439.80 ± 6.5939.94 ± 7.0439.25 ± 4.5439.33 ± 5.240.958
MAP90.77 ± 10.5792.13 ± 10.2492.21 ± 10.4792.01 ± 9.6590.44 ± 7.830.280
HR84.41 ± 13.1187.96 ± 13.0287.35 ± 12.6589.35 ± 13.2698.00 ± 20.660.026*
SpO2 88.70 ± 2.9887.94 ± 3.1988.16 ± 3.0187.06 ± 3.8187.83 ± 3.060.048*
LA29.82 ± 2.1229.70 ± 2.1829.75 ± 1.9929.40 ± 2.8430.33 ± 2.500.632
LV45.78 ± 2.2746.00 ± 2.2546.04 ± 2.2145.85 ± 2.4445.83 ± 2.320.425
RA33.98 ± 2.0434.10 ± 2.3234.14 ± 2.2734.06 ± 2.5633.17 ± 2.320.661
RV33.48 ± 2.2433.70 ± 2.5633.78 ± 2.5633.50 ± 2.6032.50 ± 2.070.469
PA19.83 ± 1.1419.95 ± 1.4219.93 ± 1.4219.98 ± 1.4820.33 ± 1.030.452
EF66.38 ± 4.2867.16 ± 4.7267.29 ± 4.8266.87 ± 4.4064.83 ± 3.310.165
SV65.92 ± 8.9667.32 ± 9.7267.57 ± 9.7966.66 ± 9.4264.17 ± 10.630.230
CO5.16 ± 1.145.60 ± 1.025.60 ± 1.035.65 ± 1.025.60 ± .6630.001**
Tricuspid regurgitation0.50(0.80)0.50(0.60)0.50(0.60)0.50(0.80)0.40(0.68)0.135
Cerebral hemodynamics
Left side MCA
Vm 67.46 ± 12.1867.41 ± 11.7466.91 ± 10.8769.35 ± 14.8768.50 ± 11.470.973
Vs 102.17 ± 14.94101.41 ± 15.91100.79 ± 15.15103.92 ± 18.83102.00 ± 15.820.693
Vd 48.0 ± 10.1247.96 ± 9.1047.51 ± 8.3749.46 ± 11.6751.00 ± 8.600.964
PI0.820 ± 0.1690.800 ± 0.1300.802 ± 0.1270.799 ± 0.1410.750 ± 0.1300.260
RI0.531 ± 0.0630.527 ± 0.04900.528 ± 0.0480.526 ± 0.0510.499 ± 0.0570.532
Left side VA
Vm 35.18 ± 5.5736.38 ± 6.1935.93 ± 5.6637.63 ± 6.5941.67 ± 14.400.103
Vs 51.28 ± 7.0552.16 ± 8.4951.75 ± 7.9353.19 ± 9.2057.83 ± 17.590.374
Vd 24.76 ± 4.7625.96 ± 4.9725.46 ± 4.4927.35 ± 5.0832.00 ± 11.930.045*
PI0.765 ± 0.1590.727 ± 0.1530.738 ± 0.1530.690 ± 0.1500.640 ± 0.1020.040*
RI0.517 ± 0.0650.500 ± 0.0610.505 ± 0.0580.482 ± 0.0700.454 ± 0.0530.025*
Right side MCA
Vm 63.51 ± 13.6764.46 ± 11.4564.24 ± 11.2664.87 ± 11.5768.67 ± 17.610.518
Vs 95.59 ± 17.6196.24 ± 15.6796.17 ± 15.5596.13 ± 15.6599.83 ± 22.290.740
Vd 45.11 ± 10.9645.75 ± 8.7345.53 ± 8.5246.12 ± 8.9550.67 ± 13.740.573
PI0.812 ± 0.1440.792 ± 0.1240.796 ± 0.1210.780 ± 0.1250.734 ± 0.1900.191
RI0.530 ± 0.0530.526 ± 0.0510.527 ± 0.0510.521 ± 0.0470.493 ± 0.0760.440
Right side VA
Vm 37.27 ± 6.1837.27 ± 6.0237.00 ± 5.8038.63 ± 6.8935.17 ± 4.660.991
Vs 52.51 ± 7.6952.26 ± 8.2952.11 ± 8.0953.42 ± 9.2147.50 ± 6.060.800
Vd 26.72 ± 5.0926.55 ± 4.7426.26 ± 4.5627.75 ± 5.3326.33 ± 4.890.764
PI0.716 ± 0.2080.693 ± 0.1170.702 ± 0.1170.669 ± .1140.606 ± 0.0560.202
RI0.500 ± 0.1190.491 ± 0.0530.494 ± 0.0520.480 ± .0530.448 ± 0.0370.317
BA
Vm 41.42 ± 8.6444.18 ± 9.7443.80 ± 9.4246.33 ± 10.9138.83 ± 8.060.017*
Vs 65.46 ± 11.5468.81 ± 14.8468.60 ± 14.3270.81 ± 16.1359.17 ± 19.630.028*
Vd 28.61 ± 7.4630.47 ± 7.5230.07 ± 7.3132.29 ± 8.3128.83 ± 6.270.042*
PI0.914 ± 0.2240.879 ± 0.1930.890 ± 0.1920.844 ± 0.1830.760 ± .2620.151
RI0.564 ± 0.0780.554 ± 0.0680.559 ± 0.0660.542 ± 0.0690.496 ± .0860.292
Asymmetry of the bilateral VAs
ΔVs −1.00 (8.00)0. 00 (9.00)0.00(9.00)0.00 (10.50)5.00 (28.5)0.126
ΔVd −3.00 (6.25)−1.00 (6.00)−1.00(7.00)−1.00 (3.75)2.00 (18.5)0.010*
ΔVm −2.50 (8.00)−1.00 (6.00)−1.00(6.00)−1.00 (4.75)1.00 (23.75)0.046*
AI%−6.6(22.0)−2.7 (18.0)−2.9(18.4)−2.1(13.8)2.8 (52.2)0.040*
Conduction
CVCi0.729 ± 0.1450.724 ± 0.1400.719 ± 0.1350.737 ± 0.1530.767 ± 0.1910.758

*p is 0.05 or less, **p is 0.01 or less

HAH was characterized with higher velocity in posterior cerebral circulation and higher HR but lower SpO2

Differences between HAH+ and HAH- groups in demographics, systemic and cerebral hemodynamics (N = 363) *p is 0.05 or less, **p is 0.01 or less HAH was characterized with higher velocity in posterior cerebral circulation and higher HR but lower SpO2 The asymmetry of the bilateral VAs, including the ΔVd (p = 0.010), ΔVm (p = 0.046) and AI (p = 0.040), in the HAH patients was significantly different than the HAH- subjects. The cerebrovascular conductance index (0.724 ± 0.140 vs.0.729 ± 0.145, respectively, p = 0.758) was similar in the HAH+ and HAH- subjects (Table 2). The Spearman’s correlation analyses demonstrated that age (r = 0.178, p = 0.001), HR (r = 0.143, p = 0.006) and CO (r = 0.175, p = 0.001) exhibited significantly positive relationships with the HAH severity, whereas the SpO2 (r = −0.148, p = 0.005) exhibited an inverse relationship. The other parameters in systemic hemodynamics were not closely associated with HAH (all p > 0.05). The anterior circulation parameters, including the velocities, PIs and RIs in the bilateral MCA, had no associations with HAH severity. With the exception of the Vs, the other parameters (Vm, Vd, PI and RI) of the BA exhibited significant associations with HAH (p was 0.023, 0.021, 0.045 and 0.042, respectively). On the left side VA, the Vd (r = 0.157, p = 0.003) and Vm (r = 0.120, p = 0.022) exhibited positive relationships with HAH, whereas the PI (r = −0.152, p = 0.004) and RI (r = −0.166, p = 0.001) were negatively correlated with HAH. The parameters on the right side of the VA were not as closely correlated with HAH. Furthermore, associations between VA asymmetries and HAH were also identified in the bilateral VAs: ΔV of Vd (r = 0.137, p = 0.009), ΔV of Vm (r = 0.105, p = 0.046) and AI (r = 0.106, p = 0.043). The relationships between HAH and the hemodynamic parameters are shown in Table 3.
Table 3

Relationships between HAH and demographic, systemic and cerebral hemodynamic parameters (N = 363)

Headache score
rprp
Demographic factorsPI−0.1520.004**
Age0.1780.001**RI−0.1660.001**
BMI0.0750.155
Right side MCA
Systemic hemodynamicsVm 0.0780.136
SBP0.0310.561Vs 0.0550.297
DBP0.0310.560Vd 0.0860.103
ΔBP0.0090.865PI−0.0990.059
MAP0.0330.535RI−0.0870.097
HR0.1430.006**
SpO2 −0.1480.005**Right side VA
LA−0.0350.507Vm 0.0390.455
LV0.0270.610Vs <0.0010.997
RA0.0100.851Vd 0.0360.499
RV0.0010.992PI−0.0830.115
PA0.0580.275RI−0.0650.215
EF0.0450.390
SV0.0350.506BA
CO0.1750.001**Vm 0.1190.023*
Tricuspid regurgitation0.0440.400Vs 0.0770.141
Vd 0.1210.021*
Cerebral hemodynamicsPI−0.1050.045*
Left side MCARI−0.1070.042*
Vm 0.0330.536
Vs 0.0180.733Asymmetry of VAs
Vd 0.0390.454ΔVs 0.0800.130
PI−0.0390.458ΔVd 0.1370.009**
RI−0.0500.345ΔVm 0.1050.046*
AI%0.1060.043*
Left side VA
Vm 0.1200.022*Conduction
Vs 0.0670.203CVCi0.0190.716
Vd 0.1570.003**

*p is 0.05 or less, **p is 0.01 or less

HAH was positively associated with HR, CO and cerebral velocities while it negatively correlated with SpO2, PIs and RIs in BA and left side VA

Relationships between HAH and demographic, systemic and cerebral hemodynamic parameters (N = 363) *p is 0.05 or less, **p is 0.01 or less HAH was positively associated with HR, CO and cerebral velocities while it negatively correlated with SpO2, PIs and RIs in BA and left side VA

Risk factors for HAH at 3700 m

Univariate logistic regression was performed for variable with a p < 0.05 in correlation analyses or significant difference between HAH+ and HAH- groups. HR, SpO2, CO, Vd, PI and RI of left side VA, velocities in BA (Vm, Vd) and ΔVd were risk factors for HAH. After adjusted regression analyses, only HR (or CO) and ΔVd were independent risk factors for HAH (Table 4).
Table 4

Univariate and adjusted logistic regression for variables at 3700 m (N = 363)

Risk factorsβ-coefficientOdds ratio(95% CI)p value
LowerUpper
Univariate logistic regression
HR0.0221.0221.0031.0420.027*
SpO2 −0.0810.9220.8511.0000.049*
CO0.4221.5241.1951.9440.001**
Left VAVd 0.0521.0531.0011.1080.046*
PI−1.5620.2100.0470.9440.042*
RI−4.4760.0110.0000.5910.026*
BAVm 0.0321.0331.0051.0610.018*
Vd 0.0441.0361.0011.0710.035*
Asymmetry of VAsΔVd 0.0631.0651.0111.1220.018*
Adjusted logistic regression
Model 1
HR0.0251.0251.0051.0450.012*
Model 2
HR0.0231.0231.0031.0440.026*
ΔVd 0.0651.0681.0131.1260.015*
Model3
CO0.4171.5171.1891.9370.001**
ΔVd 0.0631.0651.0091.1240.022*

*p is 0.05 or less, **p is 0.01 or less

Model 1: Adjusted by primary variables (SpO2, Vd in left side VA and BA);

Model 2: Adjusted by primary variables and an asymmetry data (ΔVd);

Model 3: Avoided the colinearity between HR and CO, indicated that CO and ΔVd were independent risk factors for HAH;

We just listed the variable with a p < 0.05

Univariate and adjusted logistic regression for variables at 3700 m (N = 363) *p is 0.05 or less, **p is 0.01 or less Model 1: Adjusted by primary variables (SpO2, Vd in left side VA and BA); Model 2: Adjusted by primary variables and an asymmetry data (ΔVd); Model 3: Avoided the colinearity between HR and CO, indicated that CO and ΔVd were independent risk factors for HAH; We just listed the variable with a p < 0.05

Associations between hemodynamic parameters and HAH in a subgroup of 129 subjects

In the baseline parameters, CO, Vm, PI and RI in left side VA, velocities [Vm (60.20 ± 10.37 vs. 54.29 ± 7.03 cm/s, p = 0.004), Vs (92.11 ± 14.53 vs. 85.64 ± 10.46 cm/s, p = 0.023) and Vd (41.42 ± 7.60 vs. 37.19 ± 5.50 cm/s, p = 0.005)] in right MCA were significant different between HAH+ and HAH- groups. Furthermore, CO showed a positive relationship with HAH (Table 5).
Table 5

Associations between baseline parameters and HAH (N = 129)

Differences between HAH+Correlation with HAH intensities
and HAH- groups
Headache Cases(n)HAH-(31)HAH+(98)p valuerp value
Demographic factors
Age22.71 ± 3.2123.13 ± 4.310.6160.0930.297
BMI21.41 ± 1.6722.07 ± 2.520.1750.1530.084
Smoking(yes)7(22.5%)23(23.5%)0.919//
Alcohol consumption(yes)21(67.7%)58(59.2%)0.396//
Primary headache(yes)4(12.9%)23(23.5%)0.209//
Systemic hemodynamic
SBP118.35 ± 10.81117.32 ± 12.370.6760.0180.843
DBP74.00 ± 9.2275.18 ± 11.310.5980.0590.509
ΔBP44.35 ± 6.4742.13 ± 6.370.094−0.1370.122
MAP88.78 ± 9.2989.22 ± 11.280.8430.0610.490
HR63.32 ± 11.3564.42 ± 10.100.6070.0080.930
SpO298.35 ± 1.0298.30 ± 1.100.7930.0380.670
LA31.06 ± 1.5530.87 ± 1.780.581−0.0620.484
LV45.81 ± 2.1446.71 ± 2.500.0710.1830.037*
RA35.45 ± 1.9835.78 ± 2.270.4780.1530.082
RV35.29 ± 1.8535.55 ± 2.130.5420.1090.217
PA20.06 ± 1.4620.30 ± 1.630.4810.0940.288
EF62.90 ± 5.9863.10 ± 5.340.8650.0020.978
SV62.53 ± 16.3166.55 ± 10.610.1130.0880.322
CO3.79 ± 1.014.33 ± 0.930.007**0.1770.045*
Tricuspid regurgitation0.50(1.00)0.45(1.00)0.372−0.0300.739
Cerebral hemodynamic
Left side MCA
Vm 59.61 ± 8.2463.24 ± 10.920.0910.0600.501
Vs 93.48 ± 12.1397.00 ± 15.210.2460.0620.488
Vd 40.93 ± 6.2043.62 ± 8.370.1020.0580.513
PI0.889 ± 0.1540.852 ± 0.1250.180−0.0040.960
RI0.562 ± 0.0510.550 ± 0.0470.221−0.0150.862
Left side VA
Vm 30.94 ± 5.2533.23 ± 4.970.029*0.1710.053
Vs 49.64 ± 7.1150.82 ± 7.560.4440.0830.351
Vd 20.68 ± 4.1722.26 ± 3.950.0560.1420.107
PI0.957 ± 0.1930.873 ± 0.1690.022*−0.1500.090
RI0.594 ± 0.0750.561 ± 0.0560.010*−0.1590.072
Right side MCA
Vm 54.29 ± 7.0360.20 ± 10.370.004**0.1550.080
Vs 85.64 ± 10.4692.11 ± 14.530.023*0.1250.157
Vd 37.19 ± 5.5041.42 ± 7.600.005**0.1140.200
PI0.888 ± 0.1500.855 ± 0.1460.276−0.0780.380
RI0.574 ± 0.0620.586 ± 0.0530.592−0.0930.292
Right side VA
Vm 32.77 ± 5.3034.84 ± 4.400.0320.1260.155
Vs 49.38 ± 6.8851.03 ± 6.330.2200.0730.411
Vd 22.09 ± 4.2923.64 ± 3.950.0650.1100.216
PI0.849 ± 0.1600.793 ± 0.1560.086−0.1410.110
RI0.555 ± 0.0550.534 ± 0.0610.081−0.1340.130
BA
Vm 37.55 ± 7.3640.50 ± 7.800.0650.1540.082
Vs 66.29 ± 13.6568.53 ± 13.870.4330.0540.546
Vd 23.48 ± 5.0825.69 ± 5.970.0660.1390.115
PI0.964 ± 0.2100.885 ± 0.1970.092−0.1040.239
RI0.644 ± 0.0550.621 ± .07140.108−0.0740.404
Asymmetry of bilateral VAs
ΔVs 2.0 (15.0)0.0(9.25)0.7950.0420.634
ΔVd 0.0(6.0)−2.0 (6.0)0.7030.0170.851
ΔVm −2.0 (8.0)−1.0 (7.0)0.9340.0640.468
AI%−0.061 (0.224)−0.034(0.200)0.8150.0750.398
Conduction
CVCi0.648 ± 0.1030.704 ± 0.1450.048*0.0970.275

/:binary variables that were not analyzed by Spearman’s correlation

*p is 0.05 or less, **p is 0.01 or less

Associations between baseline parameters and HAH (N = 129) /:binary variables that were not analyzed by Spearman’s correlation *p is 0.05 or less, **p is 0.01 or less Univariate logistic regression revealed that CO, Vm in both VAs and velocities in right side MCA were risk factors for HAH. However, adjusted analyses showed that CO (adjusted by Vs and Vd of right side MCA, OR: 1.613, p = 0.036 or adjusted by Vm of right side MCA OR: 1.811, p = 0.024) and Vm in right MCA (OR: 1.066, p = 0.011) or left VA (OR: 1.099, p = 0.035) were still independent predictors for HAH (Table 6).
Table 6

Univariate and adjusted logistic regression for variables at baseline to predict HAH. (N = 129)

Predictorsβ-coefficientOdds ratio(95% CI)P value
LowerUpper
Univariate logistic regression
CO0.6501.9151.1583.1680.011*
Left side VAVm 0.0951.0991.0081.1980.031*
Right side MCAVm 0.0711.0731.0211.1270.005**
Vs 0.0391.0401.0051.0760.026*
Vd 0.0871.0911.0241.1610.007**
Right side VAVm 0.0991.1041.0071.2110.035*
Adjusted logistic regression
Model 1
Left VAVm 0.0941.0991.0071.1990.035*
CO0.4781.6131.0312.5220.036*
Model 2
Right side MCAVm 0.0641.0661.0151.1210.011*
CO0.5941.8111.0803.0360.024*

Model 1: Adjusted by primary variables (Vs and Vd of right side MCA)

Model 2: Adjusted by calculated variable (Vm of right side MCA)

Baseline CO was an independent predictor for HAH at 3700 m, whereas, Vm in left VA or right MCA was also independent predictors for HAH in different models

Only the variable with a significant statistically has been listed above

* p is 0.05 or less, ** p is 0.01 or less

Univariate and adjusted logistic regression for variables at baseline to predict HAH. (N = 129) Model 1: Adjusted by primary variables (Vs and Vd of right side MCA) Model 2: Adjusted by calculated variable (Vm of right side MCA) Baseline CO was an independent predictor for HAH at 3700 m, whereas, Vm in left VA or right MCA was also independent predictors for HAH in different models Only the variable with a significant statistically has been listed above * p is 0.05 or less, ** p is 0.01 or less Furthermore, in the subgroup analysis, the change in tricuspid regurgitation from sea level to 3700 m was significantly different between the HAH+ and HAH- groups. The alterations of ΔV in Vd and Vs of the VAs and the Vm and Vd of the BA were also significantly different between the HAH+ and HAH- groups (see Additional file 1: Table S1A).

Discussion

Alterations in both systemic and cerebral hemodynamics

In the current study, we identified alterations in both systemic and cerebral hemodynamics. The HR dramatically increased between sea level and high altitudes, which is consistent with a previous study that reported a significant increase in HR after exposure to high altitude because of the activation of the parasympathetic nervous system by hypobaric hypoxic stress [15, 4, 16]. However, the SV was similar at both altitudes, which indicates the increased CO was primarily caused by the increased HR [16]. Conversely, the hypoxia also induced a reduction in the SpO2, which may result in a decrease in the delivery of oxygen and energy to organs and tissues. Furthermore, the diastolic function of the heart has been reported to decrease in high altitude environments, which may be because of the shortened cardiac diastolic phase caused by the increased HR [17, 16]. Following acute hypoxic stress, parasympathetic nervous system activation, combined with a disequilibrium in the synthesis and expression of certain vasoconstrictors and vasodilators, results in endothelial cell dysfunction (e.g., increased endothelin-1 expression vs. decreased nitric oxide level) [18, 19]. Therefore, the vasoconstriction of systemic and cerebral arteries exhibits a significant impact on the measured velocities of blood flow [20]. We demonstrated that most velocities in both the anterior and posterior cerebral circulations significantly increased. These results are similar to previous studies in which cerebral blood flow increased dramatically after high altitude exposure [21-23].

Associations between HAH occurrence and demographical data

As previously reported by our team and other researchers, HAH patients are typically older in age, which is consistent with the risk factors of primary headache at sea level and high altitude [8, 9]. Although a history of smoking and alcohol consumption did not exhibit associations with HAH, they were not precisely measured, which could be improved in future studies.

HAH is partially associated with systemic hemodynamics

HAH is a regional symptom that comprises the primary diagnostic criteria of acute mountain sickness, which is typically induced by a local and systematic factor [5, 24]. Therefore, systemic hemodynamics may be a cause of HAH because it functions to deliver blood to all organs, including the brain, which is an organ with considerably high metabolism and energy consumption. First, an increased HR exhibited a strongly positive correlation with HAH, which is consistent with the relationship between CO and HAH. The HAH patients were also characterized by increased HR and CO. Further analyses indicated that baseline CO and LV were correlated with HAH significantly. These results may be because of the nervous system changes that lead to alterations in systemic hemodynamics [19, 25, 16]. In addition, the SpO2 was inversely correlated with HAH; however, the SBP and DBP were not related to HAH, which was similar to previous studies [8, 15, 25]. A reduced SpO2 and increased HR are independent risk factors for HAH [8, 9]. These changes could result from sympathetic nervous system activation and a decreased partial pressure of oxygen, which results in a decrease in oxygen delivery to the brain, where oxygen consumption is increased during hypoxic stress [5, 9, 6]. The change in tricuspid regurgitation in HAH patients differed from the non-HAH subjects, which indicates alterations in cardiac function induced by hypoxia may be risk factors for HAH (see Additional file 1).

Cerebral hemodynamic characteristics of HAH

In the present study, we demonstrated that the velocities in both the BA and left VA in the posterior cerebral circulation were strongly associated with HAH, which is partly consistent with previous reports [26, 22, 27]. The HAH patients were characterized by an increased Vd but decreased RI and PI in the left VA. These findings imply that HAH is associated with higher blood flow but lower resistance and compliance. At the baseline, HAH+ patients were also featured with a higher Vm in VAs on both sides indicating that posterior circulation plays critical roles in HAH or it is a pathophysiological process of HAH. Furthermore, the HAH+ group also exhibited increased Vs and Vd in the BA, which supplies blood and oxygen to the cerebellum. These results are consistent with the clinical characteristics that HAH often presents (i.e., a pulsing headache), which may be caused by diastolic dysfunction in the arteries [5, 6]. The relationship between HAH and posterior, rather than anterior, cerebral circulation contributed to HAH occurrence. Of note, velocities in right MCA at baseline in HAH+ group were differed significantly from those in HAH- group. In partial agreement with the results reported for acute mountain sickness, including HAH, we did not identify an association between HAH and anterior circulation as assessed by the velocities, PI and RI of the bilateral MCAs [28]. However, these results were inconsistent with the previously reported that acute mountain sickness related headache usually presents as frontal headache [5]. The inconsistence may be caused by the sample size in the subgroup of 129 participants. Though the baseline conduction from systemic to cerebral blood flow, which was evaluated using the cerebrovascular conductance index, showed a significant difference between HAH+ and HAH- groups, it is not predictor for HAH. Furthermore, it was not associated with HAH at 3700 m, which indicates cerebral blood flow plays a primary role in HAH and has more critical importance than systemic hemodynamics.

Predictors and risk factors for HAH

After adjusted regression analyses at baseline, we identified that CO and Vm in left VA (or right MCA in different regressions) were independent predictors for HAH. However, the posterior and anterior circulations were not valuable in a same model. Other adjusted analyses at 3700 m revealed that only HR (or CO) and ΔVd were independent risk factors for HAH, which is partly consistent with our and others’ previous studies. However, ΔVd was found to be a novel risk factor for HAH which may be caused by the hypoxia induced local expressions of vasoactive substances. Furthermore, the variation in VAs of Chinese Han in anatomy may also be a reason for our findings.

Relationship between HAH and VA asymmetry

We report a novel finding in that VA asymmetry was closely related to HAH. An asymmetry in the bilateral isonym VA exists under normal physiological conditions [21, 28, 29]. However, this physiological asymmetry could become a considerable or pathological irregularity because of its amplification by hypoxia-induced vasodilatation and an impaired auto-regulation of cerebral blood flow following acute high-altitude exposure [21]. Furthermore, HAH severity was closely associated with the VA asymmetry, which represents a characteristic that has not been previously reported. This finding may be associated with the region of blood flow and perfusion in the cortex and cerebellum. It may also be related to the clinical characteristics of the migraine pattern present in many HAH patients [5]. The variance between the isonym VAs may contribute to the development of HAH and requires further examination to identify its precise pathophysiological mechanisms. HAH comprises multifactorial components [30, 12, 31, 14]. Therefore, the cerebral and systemic hemodynamic characteristics of HAH may be relevant to the disease development, as well as its pathophysiological processes and clinical manifestations.

Limitations

Our study was restricted to young Chinese men, which could potentially generate a bias regarding age or gender; thus, this issue should be addressed in future studies. Another limitation is that a key modulator of cerebral perfusion, partial pressure of carbon dioxide (PaCO2), was not measured in the present study. This modulator could be included in future mechanistic studies. Another limitation is that headache satisfied the diagnostic criteria of the International Classification of Headache Disorders basically. Although the descent was not performed immediately after the onset of the headache, cephalalgia almost resolved as time went on. Furthermore, the subjects were all newcomers from sea level, thus none of them with a history of HAH or acute mountain sickness history, which should be improved in future study.

Conclusions

HAH is characterized, in part, by increased systemic hemodynamics and posterior cerebral circulation as reflected by the velocities in the BA and left VA, as well as lower arterial resistance and compliance. Furthermore, baseline CO and Vm in left VA or right MCA at sea level are independent predictors for HAH, whilst bilateral VA asymmetry may contribute to the development of HAH at high-altitude.
  30 in total

Review 1.  Acute mountain sickness: pathophysiology, prevention, and treatment.

Authors:  Chris Imray; Alex Wright; Andrew Subudhi; Robert Roach
Journal:  Prog Cardiovasc Dis       Date:  2010 May-Jun       Impact factor: 8.194

2.  Alternations of heart rate variability at lower altitude in the predication of trekkers with acute mountain sickness at high altitude.

Authors:  Hsien-Hao Huang; Chia-Ying Tseng; Ju-Sing Fan; David Hung-Tsang Yen; Wei-Fong Kao; Shi-Chuan Chang; Terry B J Kuo; Chun-I Huang; Chen-Hsen Lee
Journal:  Clin J Sport Med       Date:  2010-01       Impact factor: 3.638

3.  Cerebral vasomotor reactivity at high altitude in humans.

Authors:  G F Jansen; A Krins; B Basnyat
Journal:  J Appl Physiol (1985)       Date:  1999-02

4.  Intracranial hypotension: aggravation of headache at high altitude.

Authors:  John A Batsis; Michael P Phy
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

5.  Cerebrovascular responses to hypoxia and hypocapnia in high-altitude dwellers.

Authors:  L J Norcliffe; M Rivera-Ch; V E Claydon; J P Moore; F Leon-Velarde; O Appenzeller; R Hainsworth
Journal:  J Physiol       Date:  2005-04-28       Impact factor: 5.182

6.  Risk factors for high-altitude headache in mountaineers.

Authors:  Martin Burtscher; Klemens Mairer; Maria Wille; Gregor Broessner
Journal:  Cephalalgia       Date:  2011-01-10       Impact factor: 6.292

7.  Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study.

Authors:  R W Baumgartner; I Spyridopoulos; P Bärtsch; M Maggiorini; O Oelz
Journal:  J Appl Physiol (1985)       Date:  1999-05

8.  Efficacy of oxygen inhalation in sumatriptan refractory "high altitude" cluster headache attacks.

Authors:  Edoardo Mampreso; Ferdinando Maggioni; Federica Viaro; Caterina Disco; Giorgio Zanchin
Journal:  J Headache Pain       Date:  2009-09-25       Impact factor: 7.277

9.  Risk factors for high-altitude headache upon acute high-altitude exposure at 3700 m in young Chinese men: a cohort study.

Authors:  Shi-Zhu Bian; Ji-Hang Zhang; Xu-Bin Gao; Ming Li; Jie Yu; Xi Liu; Jun-Qing Dong; Guo-Zhu Chen; Lan Huang
Journal:  J Headache Pain       Date:  2013-04-11       Impact factor: 7.277

10.  Cerebral hemodynamic characteristics of acute mountain sickness upon acute high-altitude exposure at 3,700 m in young Chinese men.

Authors:  Shi-Zhu Bian; Jun Jin; Qian-Ning Li; Jun Qin; Ji-Hang Zhang; Shi-Yong Yu; Jian-Fei Chen; Cai-Fa Tang; Lan Huang
Journal:  Eur J Appl Physiol       Date:  2014-07-05       Impact factor: 3.078

View more
  8 in total

Review 1.  When Headache Warns of Homeostatic Threat: the Metabolic Headaches.

Authors:  Parneet Grewal; Jonathan H Smith
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

2.  Systemic Blood Predictors of Elevated Pulmonary Artery Pressure Assessed by Non-invasive Echocardiography After Acute Exposure to High Altitude: A Prospective Cohort Study.

Authors:  Shi-Zhu Bian; Chen Zhang; Rong-Sheng Rao; Xiao-Han Ding; Lan Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-10

3.  Hematological Risk Factors for High-Altitude Headache in Chinese Men Following Acute Exposure at 3,700 m.

Authors:  He Huang; Bao Liu; Gang Wu; Gang Xu; Bing-Da Sun; Yu-Qi Gao
Journal:  Front Physiol       Date:  2017-10-17       Impact factor: 4.566

4.  Study on the Optimization and Oxygen-Enrichment Effect of Ventilation Scheme in a Blind Heading of Plateau Mine.

Authors:  Zijun Li; Rongrong Li; Yu Xu; Yuanyuan Xu
Journal:  Int J Environ Res Public Health       Date:  2022-07-18       Impact factor: 4.614

5.  Study on Oxygen Supply Standard for Physical Health of Construction Personnel of High-Altitude Tunnels.

Authors:  Chun Guo; Jianfeng Xu; Mingnian Wang; Tao Yan; Lu Yang; Zhitao Sun
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

6.  Principal Component Analysis and Risk Factors for Acute Mountain Sickness upon Acute Exposure at 3700 m.

Authors:  Shi-Zhu Bian; Jun Jin; Ji-Hang Zhang; Qian-Ning Li; Jie Yu; Shi-Yong Yu; Jian-Fei Chen; Xue-Jun Yu; Jun Qin; Lan Huang
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

7.  Physiological, hematological and biochemical factors associated with high-altitude headache in young Chinese males following acute exposure at 3700 m.

Authors:  Kun Wang; Menghan Zhang; Yi Li; Weilin Pu; Yanyun Ma; Yi Wang; Xiaoyu Liu; Longli Kang; Xiaofeng Wang; Jiucun Wang; Bin Qiao; Li Jin
Journal:  J Headache Pain       Date:  2018-07-25       Impact factor: 7.277

8.  Association of EPAS1 and PPARA Gene Polymorphisms with High-Altitude Headache in Chinese Han Population.

Authors:  Yang Shen; Jihang Zhang; Jie Yang; Chuan Liu; Shizhu Bian; Chen Zhang; Jie Yu; Xubin Gao; Lan Huang
Journal:  Biomed Res Int       Date:  2020-02-24       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.